Anti-μ-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: Evidence for a role in apoptotic immune cell death

Blood

Volumn 100, Issue 9, 2002, Pages 3261-3268

  Macé, Gaëtane ^a   Jaume, Martial ^a   Blanpied, Catherine ^a   Stephan, Lionel ^a   Coudert, Jérôme D ^a   Druet, Philippe ^a   Dietrich, Gilles ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CHO CELL; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MOUSE; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; SENSITIZATION; SEQUENCE HOMOLOGY; SPLEEN CELL;

EID: 0036839311     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0055     Document Type: Article

References (55)

1. Straub RH, Westermann J, Schölmerich J, Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today. 1998;19:409-413.
2. Kohm AP, Sanders VM. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol. 1999;162:5299-5308.
3. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 1987;238:524-526.
4. Suzuki R, Furuno T, McKay DM, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol. 1999;163:2410-2415.
5. Pozo D, Delgado M, Martinez C, et al. Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today. 2000;21:7-11.
6. Neumann H, Schmidt H, Wilharm E, Behrens L, Wekerle H. Interferon γ gene expression in sensory neurons: Evidence for autocrine gene regulation. J Exp Med. 1997;186:2023-2031.
7. Marz P, Cheng J-G, Gadient RA, et al. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A. 1998;95:3251-3256.
8. Cabot PJ, Carter L, Gaiddon C, et al. Immune cell-derived β-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest. 1997;100:142-148.
9. Shavit Y, Depaulis A, Martin FC, et al. Involvement of brain opiate receptors in the immunosuppressive effect of morphine. Proc Natl Acad Sci U S A. 1986;83:7114-7117.
10. Gavériaux-Ruff C, Matthes HWD, Peluso J, Kieffer BL. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene. Proc Natl Acad Sci U S A. 1998;95:6326-6330.
11. Govitrapong P, Suttitum T, Kotchabhaki N, Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther. 1998;286:883-889.
12. Grimm MC, Ben-Baruch A, Taub DD, et al. Opiates transdeactivate chemokine receptors: δ and μ opiate receptor-mediated heterologous desensitization. J Exp Med. 1998;188:317-325.
13. Roy S, Cain KJ, Chappin RB, Charboneau RG, Barke RA. Morphine modulates NFκB activation in macrophages. Biochem Biophys Res Commum. 1998;245:392-396.
14. Matthes HWD, Maldonado R, Simonin F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 1996;383:819-823.
15. Yin D, Mufson A, Wang R, Shi Y. Fas-mediated cell death promoted by opioids. Nature. 1999;397:218.
16. Yin D, Tuthill D, Mufson R, Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med. 2000;191:1423-1428.
17. Avrameas S. Natural autoantibodies: From 'horror autotoxicus' to 'gnothi seauton.' Immunol Today. 1991;12:154-159.
18. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med. 1998;188:2381-2386.
19. Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156-2159.
20. Hansen MB, Svenson M, Abell K, Yasukawa K, Diamant M, Bendtzen K. Influence of IL-6 autoantibodies on IL-6 binding to cellular receptors. Eur J Immunol. 1995;25:348-354.
21. Svenson M, Hansen MB, Ross C, et al. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood. 1998;91:2054-2061.
22. Macé G, Blanpied C, Emorine LJ, Druet P, Dietrich G. Isolation and characterization of natural human IgG with a morphine-like activity. Eur J Immunol. 1999;29:997-1003.
23. Macé G, Blanpied C, Emorine LJ, Druet P, Dietrich G. Morphine-like activity of natural human IgG autoantibodies is because of binding to the first and third extracellular loops of the μ-opioid receptor. J Biol Chem. 1999;274:20079-20082.
24. Druet E, Praddaude F, Druet P, Dietrich G. Non-Ig serum proteins prevent the binding of IgG from normal rats and from rats with Th2-mediated autoimmune glomerulonephritis to various autoantigens including glomerular antigens. Eur J Immunol. 1998;28:183-192.
25. Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides. Cell Mol Neurobiol. 1995;15:615-635.
26. Saoudi A, Simmonds S, Huitinga I, Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: Evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med. 1995;182:335-344.
27. Macé G, Jaume M, Druet E, et al. Identification of μ-opioid receptor epitopes recognized by agonistic IgG. Biochem Biophys Res Commun. 2001;280:1142-1147.
28. Kaithamana S, Fan J, Osuga Y, Liang SG, Prabhakar BS. Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol. 1999;163:5157-5164.
29. Haury M, Sundblad A, Grandien A, Barreau C, Coutinho A, Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol. 1997;27:1557-1563.
30. Roy BF, Bowen WD, Frazier JS, et al. Human antiidiotypic antibody against opiate receptors. Ann Neurol. 1988;24:57-63.
31. Shah NP. Effects of milk-derived bioactives: An overview. Br J Nutr. 2000;84(suppl 1):S3-S10.
32. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812-818.
33. Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216:117-137.
34. Strakosch CR, Wenzel BE, Row VV, Volpe R. Immunology of autoimmune thyroid diseases. N Engl J Med. 1982;307:1499-1507.
35. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952.
36. Eftekhari P, Salle L, Lezoualc'h F, et al. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol. 2000;30:2782-2790.
37. Borda T, Perez Rivera R, Joensen L, Gomez RM, Sterin-Borda L. Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: Molecular interaction. J Immunol. 2002;168:3667-3674.
38. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995;16:569-574.
39. Siegel RM, Ka-Ming Chan F, Chun HJ, Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol. 2000;1:469-474.
40. Spielman J, Lee RK, Podack ER. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol. 1998;161:7063-7070.
41. 2-adrenoceptor antibody behave as antagonists. Mol Pharmacol. 2000;58:373-379.
42. He L, Fong J, von Zastrow M, Whistler JL. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell. 2002;108:271-282.
43. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 1996;271:16384-16392.
44. Singhal PC, Bhaskaran M, Patel J, et al. Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol. 2002;168:4025-4033.
45. Suzuki S, Miyagi T, Chuang TK, Chuang LF, Doi RH, Chuang RY. Morphine upregulates μ opioid receptors of human and monkey lymphocytes. Biochem Biophys Res Commun. 2000;279:621-628.
46. Wick MJ, Minnerath SR, Roy S, Ramakrishnan S, Loh HH. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol. 1996;64:29-36.
47. Gavériaux C, Peluso J, Simonin F, Laforet J, Kieffer B. Identification of κ and δ receptor transcripts in immune cells. FEBS Lett. 1995;369:272-276.
48. Sedqi M, Roy S, Ramakrishnan S, Elde R, Loh HH. Complementary DNA cloning of a μ-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun. 1995;209:563-574.
49. Garban HJ, Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: A pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J Immunol. 2001;167:75-81.
50. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, Gibbons N. Morphine enhances macrophage apoptosis. J Immunol. 1998;160:1886-1893.
51. Sei Y, Yoshimoto K, McIntyre T, Skolnick P, Arora PK. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J Immunol. 1991;146:194-198.
52. Fuchs BA, Pruett SB. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J Pharmacol Exp Ther. 1993;266:417-423.
53. Lawrence DMP, el-Hamouly W, Archer S, Leary JF, Bidlack JM. Identification of κ opioid receptors in the immune system by immunofluorescence. Proc Natl Acad Sci U S A. 1995;92:1062-1066.
54. Sedqi M, Roy S, Ramakrishnan S, Loh HH. Expression cloning of a full-length cDNA encoding δ opioid receptor from mouse thymocytes. J Neuroimmunol. 1996;65:167-170.
55. Linner KM, Quist HE, Sharp BM. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J Immunol. 1995;154:5049-5060.